# How Should Startup Founders and Employees Plan QSBS Equity in 2026?

aistructuralreview.com · September 27, 2026

> What QSBS Startup Equity Planning Actually Covers Qualified Small Business Stock, or QSBS, is U.S. federal tax treatment for otherwise taxable capital...

## What QSBS Startup Equity Planning Actually Covers

Qualified Small Business Stock, or QSBS, is U.S. federal tax treatment for otherwise taxable capital gains realized on the sale or exchange of stock issued by a qualifying small business. For a stock purchase, the base exclusion permits eligible taxpayers to exclude a limited portion of the gain rather than treating the entire gain at ordinary capital-gains rates. Historically, the exclusion reached $10 million for most taxpayers and could increase with inflation, while acquisition cost per issuer was subject to a separate limit. Congress changed several parameters through the One Big Beautiful Bill Act, making the post-2025 rules more generous for qualifying grants of newly issued stock.

**Also worth reading:** [How Do Founders and Investors Navigate QSBS Valuation Planning Under OBBBA?](https://aistructuralreview.com/knowledge/how_do_founders_and_investors_navigate_qsbs_valuation_planning_under_obbba.php) · [What Is Section 1202 Compliance Software and Do Founders Actually Need It in 2026?](https://aistructuralreview.com/knowledge/what_is_section_1202_compliance_software_and_do_founders_actually_need_it_in_2026.php) · [How Do Founders Maintain Qualified Small Business Stock Compliance for AI Engineering Firms?](https://aistructuralreview.com/knowledge/how_do_founders_maintain_qualified_small_business_stock_compliance_for_ai_engineering_firms.php)

A company does not sell a “QSBS benefit” to employees, and the tax exclusion does not automatically apply to every founder or worker. It depends on the company qualifying as a small business, the holder meeting applicable tax-residency rules, the stock being issued and substantially meeting statutory operating and asset tests, and the required holding period being satisfied. QSBS planning is therefore the process of preserving eligibility while matching equity grants, exercise decisions, transactions, liquidity events, and tax reserves to a founder’s or employee’s overall financial plan.

The traditional purchase-price limit was $10 million, adjusted for inflation, and the income limitation has been substantially increased for grants made after enactment of the 2025 legislation. Exact transition rules, issuer eligibility, and calculations are technical enough that the acquisition date and issuing entity must be checked. The exclusion also concerns stock, not automatically cash, salary, bonuses, or the value of an unexercised option. For a technical founder, principal engineer, or AI architecture leader, this means the first planning task is to reconstruct the company’s current QSBS status rather than assume the label used by the equity administrator is legally complete.

The basic gain exclusion remains a 0%, 50%, 75%, or 100% exclusion depending on the holding period under the traditional rules. The legislative changes discussed below introduce longer holding periods and more favorable exclusions for stock acquired under the expanded regime, but the precise rule depends on issuance date, sale date, amended tax return status, and the taxpayer. That complexity makes competent tax review appropriate, but it does not justify dismissing a large equity benefit as insignificant.

## How the Traditional and Expanded QSBS Rules Work

Under the long-standing Section 1202 framework, eligible gain is generally excluded to the extent of the lower of the applicable income-based cap or the issuer-specific acquisition-cost cap. A QSBS issuer generally must have gross assets at or below $50 million before the acquisition, use at least 80% of its assets in the active conduct of a trade or business, and derive at least 80% of gross receipts from that business. A corporation, partnership, or S corporation otherwise qualifies only if substantially all voting stock is held by one or more individuals directly or indirectly through a limited liability company or similar disregarded entity.

Holding the stock produces four main federal exclusion levels: 0% after less than five years, 50% after at least five years, 75% after at least six years, and 100% after at least seven years. For a 20% federal long-term capital-gains rate, those levels correspond to effective federal rates of approximately 20%, 15%, 10%, and 0% on the excluded gain, before state taxes and the alternative minimum tax. The calculation uses gain attributable to the QSBS itself, which may differ from the company’s total equity value because of grant price, exercise price, taxes, transaction expenses, and the holder’s basis.

The One Big Beautiful Bill Act, signed on July 4, 2025, materially expanded several QSBS parameters for applicable new grants. It increased the general income-based limitation for eligible taxpayers to an inflation-adjusted $20 million and raised the company gross-assets threshold from $50 million to $75 million. It also created a 10-year 75% exclusion and a 15-year 100% exclusion for stock issued after July 4, 2025, replacing the former seven-year full-exclusion endpoint for that new category. The regular grants may be structured with repurchase rights, but exercise timing and repurchase risk can affect qualification.

These changes should not be blended mechanically with older grants. Original-issue stock, converted or exercised options, restricted stock, and stock acquired by a controlled holding entity can produce different holding periods and acquisition-price limits. As of September 27, 2026, planning also requires checking the implementing regulations, Internal Revenue Service guidance, and transition provisions published after enactment. A statement that “QSBS now has a 15-year clock” is incomplete if the issuer is assumed to qualify under older rules or the taxpayer is relying on early repurchase provisions.

## Why Companies and Technical Leaders Should Plan Before a Liquidity Event

QSBS eligibility can change as a company hires, restructures, raises capital, acquires businesses, or grows out of the small-business thresholds. A company that is an eligible startup during the grant period may later fail a gross-assets, receipts, active-business, or voting-stock test. Officers and employees can also create issues by owning stock through multiple entities, selling related-company securities in the same transaction, or exercising repurchase rights too early. Planning early creates a record of those risks and may identify a restructuring route before the company approaches a strategic sale or public listing.

The most valuable planning often occurs before the company has a very high valuation. At that point, a company can consider whether grants should be structured as original issue rather than secondary sales, whether exercise dates should be staged, and whether a repurchase right can be designed consistently with the longer holding rules. These are not automatic recommendations: employee retention, fair value compliance, Internal Revenue Code Section 409A, securities law, and the employer’s future financing needs all matter. Equity cannot be deliberately withheld or repurchased solely to manufacture a tax preference if the arrangement lacks a legitimate business purpose.

For founders and senior AI engineering leaders, the issue is not merely personal tax. A technically qualified executive may influence hiring strategy, product direction, or corporate governance, so the tax benefit is not a substitute for assessing whether the company’s stated operating metrics are real and durable. A qualifying “small business” generally must conduct an active trade or business; passive investment assets, cash management, certain investments, and some corporate arrangements do not help satisfy the test. Documenting active software operations, research and development activity, customer contracts, and business-related use of assets is preferable to treating legal classification as equivalent to economic substance.

Planning is especially relevant before a tender offer, acquisition, IPO filing, secondary transaction, estate-planning transfer, or planned departure. The headline valuation is not the taxable amount, and an employee’s gain may be much smaller because exercise prices and taxes consume basis. Conversely, highly appreciated restricted stock can create a meaningful tax bill even when the employee receives only a modest fraction of the company’s total shares. A written model that isolates QSE, ISO, NSO, cash, and assumed proceeds makes that difference visible.

## A Practical Four-Stage Planning Process

The first stage is document reconstruction. The employee should obtain the grant agreement, vesting schedule, grant date, issue date, original issue price, latest 409A valuation, exercise history, cap table, prior Form 83(b) elections, and every repurchase or cancellation agreement. A tax team should also request the company’s asset, revenue, and active-business information as of relevant dates, along as its organizational chart and voting-stock ownership. These records establish more than current status: some tests are measured at acquisition, while holding conditions and special subsidiary rules may require an updated review.

The second stage is modeling. The planner should compare qualified stock with the value of unrestricted stock, bonuses, deferred cash, and diversified investments, rather than comparing only two rates on the same gain. For unrestricted stock, the more valuable instrument may be an ISO, which can also provide an exclusion under Section 421(b) if the stock satisfies that separate requirement. QSBS planning should not cause a founder to accept a lower pretax award when the ISO, restricted-stock, charitable-donation, or installment-sale treatment has greater after-tax value. The relevant comparison is expected after-tax value, estimated timing risk, and the amount of capital the employee can reasonably keep invested.

The third stage is timing. The worker should avoid exercise, vesting, repurchase, and sale dates that fall near eligibility breakpoints unless the timing difference has business meaning. A five-, six-, seven-, ten-, or fifteen-year threshold can alter the result, but a transaction forced by a failed company, security restrictions, or cash need may make the most tax-efficient holding period irrelevant. Conversely, high-rate taxpayers with little need for diversification gains and employee plans requiring action can benefit from a staged plan. Legal documents must be reviewed before relying on an early-exercise concept, because option terms cannot safely be rewritten merely for tax convenience after issuance.

The fourth stage is transaction preparation. Before a liquidity event, the company and individual should run a parallel Section 1202, Section 421(b), and ordinary capital-gains analysis, confirm the buyer and seller responsibilities, and reserve federal, state, payroll, and alternative-minimum-tax funds. A QSBS return usually does not shift tax withholding to the buyer in the same way that a Section 421(b) transaction may affect the exercise or sale process. The individual should not use an exclusion for planning cash availability before receiving a final return position and confirming the issuer’s eligibility documentation.

## QSBS Compared with ISOs, NSOs, and Ordinary Stock

| Feature | QSBS treatment | ISO treatment | NSO treatment | Taxable stock |
| --- | --- | --- | --- | --- |
| Main benefit | Limited capital-gain exclusion based on company qualification and holding period | Potential exclusion of ordinary-income compensation component and qualifying gain | No equivalent Section 421(b) exclusion; favorable long-term rate may remain | Ordinary compensation and capital-gain rules |
| Key issuer condition | Active small business plus asset, receipts, and voting tests | Actual ordinary-income property and favorable issuer terms | Employer plan terms | None specific to equity treatment |
| Tax rate benefit | Up to 100% exclusion of eligible gain under applicable rules | May move compensation treatment to capital gains | Often limited advantage versus a covered ISO | No equity-specific relief |
| Risk | Eligibility can be lost because of growth, structure, or transactions | Issuer and grant terms may fail Section 421(b) tests | Ordinary compensation element | Headline value can be misleading because basis is small |
| Planning focus | Qualifying grant, holding, entity, and issuer evidence | Exercise price, term, holding, fair value, and issuer compliance | Exercise cost and fair value | Basis, holding, tax rate, and concentration |

The table should not be read as three mutually exclusive choices because an instrument can fail ISO requirements and still be QSBS, or QSBS can complement an ISO analysis. A high-growth employee is often better served by an ISO economically, even when the company is not small enough for QSBS, because ISO treatment can address the bargain element that otherwise creates substantial ordinary income. A startup may be too small to issue a large ISO because the fair market value of the restricted stock cannot exceed the option exercise price, although alternatives such as early exercise and cash bonus arrangements can change the calculation.
Restricted stock and RSUs also require a basis analysis at grant and vest dates, and the worker must watch the one-year 83(b) election deadline for substantial risk of forfeiture. A Form 83(b) election generally must be filed with the employer within 30 calendar days of the restricted-stock grant, not within 30 days of vesting. It can produce ordinary income at grant based on the then-lowest possible value, so filing too early can also be expensive. The choice is not an administrative formality, and both QSBS eligibility and 83(b) treatment should be evaluated using the actual instrument.

Cash compensation, bonus structures, and diversification can outperform more elaborate equity maneuvers. The 20% federal long-term rate means that converting additional gain into qualified gain creates meaningful savings, but preserving qualified status is only worth the sacrifice if the individual can tolerate company and asset concentration. An employee who cannot afford to wait seven or fifteen years, who needs liquidity, or who holds a diversified portfolio may be better off negotiating an ISO or larger cash package. The right plan is the one with the highest risk-adjusted after-tax value, not necessarily the largest nominal tax exclusion.

## Costs, Advisor Scope, and Decision Value

There is no universal market price for QSBS startup equity planning. A self-directed model using company records and generic calculators may cost nothing, but it can miss issuer, acquisition-date, or Section 1202(d)(3) issues. Specialized startup-equity advice commonly ranges from a few hundred dollars for a document-limited review to several thousand dollars for a modeled founder or executive plan. Ongoing CFI, fund, or transaction work can cost more, while top-tier firms may charge substantially more for a full tax, legal, and liquidity analysis. Fees are not evidence that a plan is correct, and a high fee does not replace issuer diligence or a written scope.

The buyer of the advice should be clear. Employees need a private tax model and rollover plan; the employer needs a legally defensible company analysis, cap-table administration, and coordination with payroll and corporate counsel. Some start-up-as-a-service firms provide a company-level eligibility opinion, but that does not necessarily cover the individual’s basis, tax bracket, residence, or exit date. A beneficial-stock opinion should define the period covered, the information reviewed, assumptions, issuance dates tested, and whether later transactions are outside the conclusion.

A lower-cost alternative is a staged review. First, the employee can gather the grant and cap-table records and request a basic gross-assets and voting-stock screen from the company. Next, a CPA or tax attorney can perform a focused acquisition-date review and compare likely exit years. The full engagement is justified when the potential excluded gain is large, the issuer is close to an asset threshold, there is a transaction within 12 to 24 months, or the employee holds through a controlled entity. A simple RSO with limited appreciation may justify a spreadsheet and basic tax advice rather than a comprehensive engagement.

Price is only one part of the decision. The value of advice includes catching a missed ISO, preventing an invalid 83(b) election, modeling withholding, identifying a disqualifying early sale, or aligning a repurchase right with the correct holding rule. The downside includes overengineering the award, delaying planned exercise, and accepting tax complexity for a benefit unavailable on a compulsory sale. A good adviser should provide a break-even point showing when the expected federal and state tax savings justify the planning and transaction costs.

## Common Mistakes That Can Destroy Eligibility

The most frequent mistake is treating QSBS as a permanent company label. An issuer can qualify for one issuance and fail later, and a particular employee can fail a holding requirement even when the startup remains eligible. Other common errors include assuming an option was issued on the vesting date, overlooking employer stock, using the sale price instead of the holder’s realized gain as the exclusion base, and combining gain from several companies without applying each issuer’s separate acquisition-cost cap. A third mistake is holding through a prohibited individual or entity arrangement, particularly when stock moves among family members or controlled entities with different ownership patterns.

Timing errors are equally costly. Selling before the relevant holding period, exercising a repurchase right too early, or taking a cash payment instead of exercising within a specified window can change the result. A company may also fail because a very long holding period is incompatible with its planned liquidity event, and employees should not impose unsuitable restrictions on a startup merely to protect a federal tax benefit. Transaction structures should reflect genuine business constraints and comply with securities, accounting, fiduciary, and contractual requirements.

State tax is a separate issue. QSBS can provide federal relief while the employee remains subject to state individual income tax or an equivalent state-level charge on the same gain. A later residency change can also complicate the year in which the gain is recognized. Employers and investors should not describe an excluded QSBS gain as “tax-free” without specifying that the statement concerns only a limited portion of federal gain and may not cover state tax, alternative minimum tax, payroll effects, or transaction deductions. Accurate modeling should use the worker’s actual jurisdiction rather than assuming one nationwide answer.

Finally, a bad inference about original issue stock can create exposure. Secondary transactions, investor shares, transferred options, and stock issued in connection with debt repayment may be treated differently from new employee compensation. Twenty-four months after acquisition must be a planning checkpoint, not an automatic deadline, because the statutory language and case law require attention to the particular grant, capitalization, transaction, and ownership history. This is why a general tax article cannot substitute for a fact-specific review when a large award is involved.

## When to Act in 2026 and Beyond

Planning should begin before the company crosses the applicable $75 million expanded asset ceiling or changes its business mix, and before a tender offer, acquisition, or IPO creates a narrow response window. For a founder with eight years of service but a planned sale in year six, the available benefit is limited unless the transaction or holding arrangement changes legitimately. For an employee approaching a five-year threshold, reviewing plan documents before year five is more useful than calculating after the sale closes. The 2025 legislation increases the potential benefit of longer holds, but it does not make every historical option eligible for the new 10- or 15-year treatment.

The issuer should monitor the business tests at least annually and before material transactions, while the employee should review the plan annually and after any exercise, tender, secondary sale, or relocation. If the company is rapidly approaching a threshold, the current ownership and asset structure should be tested now. If a startup is intentionally remaining private because a consolidated AI infrastructure business requires several more years of investment, the tax benefit may become only one of several reasons to wait. Operational runway, employee retention, acquisition terms, and concentration risk usually outweigh a marginal rate difference.

A QSBS plan is most defensible when it is documented before the economic event it affects, uses accurate legal and financial records, and includes a clear reason for every restricted or staged exercise. It should be revised when law or administrative guidance changes, because Treasury rulemaking and Internal Revenue Service guidance can resolve questions that appear straightforward in general summaries. As of September 27, 2026, advisers and startup operators should compare the enacted legislation with the latest regulations, temporary rules, employer documentation, and their own acquisition dates rather than relying on pre-2025 articles.

For the AI structural engineering context, the practical point is that the emerging company’s tax identity does not replace technical and corporate discipline. A company developing AI systems should maintain reliable evidence of active research, software products, customer deployments, intellectual-property ownership, and business-related computing expenditure. Those records can help with tax, diligence, and financial reporting, but the operating substance must genuinely exist. QSBS planning should therefore be integrated into responsible startup equity administration, not treated as a reason to exaggerate growth, complicate employee agreements, or weaken sound AI engineering governance.

## Quick answers

### Does QSBS mean an employee pays no tax when selling startup stock?

No. QSBS generally excludes only a limited portion of eligible gain, and the exclusion depends on issuer status, acquisition rules, holding time, and the separate issuer acquisition-price cap. Federal alternative minimum tax, state tax, payroll tax, and other charges may still apply.

### Can an ISO also qualify as QSBS?

Yes, an equity grant can be analyzed under both statutory regimes, although the tests differ. ISO treatment may be economically more valuable because it can address ordinary-income compensation, while QSBS depends mainly on the issuer and capital-gain holding requirements.

### Did the 2025 tax law change the QSBS seven-year rule for every grant?

No. The expanded 10-year 75% and 15-year 100% categories apply to qualifying stock issued under the new rules, generally requiring issuance after July 4, 2025. Older grants must be evaluated under the applicable pre-enactment holding structure and transition provisions.

### What should a startup prepare for a QSBS eligibility review?

The company should provide a dated cap table, grant records, organizational chart, asset ledger, financial statements, gross-receipts information, and descriptions of active business operations. The company must also explain investments, related entities, financing transactions, and any stock repurchase or cancellation rights.

### How much does professional QSBS planning cost?

A limited document review may cost several hundred dollars, while a detailed founder or executive analysis often costs several thousand dollars. Complex fund, acquisition, or multi-entity planning can cost more, so the adviser should state the scope, assumptions, and expected tax benefit before engagement.

Canonical: https://aistructuralreview.com/knowledge/how_should_startup_founders_and_employees_plan_qsbs_equity_in_2026.php
Markdown: https://aistructuralreview.com/knowledge/how_should_startup_founders_and_employees_plan_qsbs_equity_in_2026.php/index.md